Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autophagy and autoimmunity crosstalks.
HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis.
The prevalence of multiple sclerosis in the city of Santos has remained unaltered for five years.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
7 Tesla MRI demonstrates vascular pathology in Balo's concentric sclerosis.
Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).
The multiple sclerosis visual pathway cohort: understanding neurodegeneration in MS.
Lingo-1 Inhibited by RNA Interference Promotes Functional Recovery of Experimental Autoimmune Encephalomyelitis.
Remission with fingolimod in a case of demyelinating polyneuropathy.
Sodium channel Nav1.8: Emerging links to human disease.
The Role of ATP-Binding Cassette Transporters in Neuro-Inflammation: Relevance for Bioactive Lipids.
Modulation of B Cell Regulatory Molecules CD22 and CD72 in Myasthenia Gravis and Multiple Sclerosis.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
[Vitamin D and multiple sclerosis : The role for risk of disease and treatment.]
Clinical predictors of an optimal response to natalizumab in multiple sclerosis.
The Evaluation of the Retinal Nerve Fiber Layer in Multiple Sclerosis with Special-Domain Optical Coherence Tomography.
Cognitive reserve and cortical atrophy in multiple sclerosis: A longitudinal study.
Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis.
Autologous Haematopoietic Stem Cell Transplantation with Reduced Intensity Conditioning in Multiple Sclerosis.
Alemtuzumab treatment of multiple sclerosis.
Vitamin D: Health Panacea or false Prophet?
A Randomized Trial Evaluating Various Administration Routes of Natalizumab in Multiple Sclerosis.
[Will multiple sclerosis (MS) susceptibility genes one day become biomarkers for MS diagnosis?]
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.

Pages